Health Equity: 07/07/11

Thursday, July 7, 2011

[EQ] UN The Millennium Development Goals Report 2011

The Millennium Development Goals Report 2011

United Nations New York, July 7, 2011

UN Department of Economic and Social Affairs

Available online PDF [72p.] at: http://bit.ly/niNndt

“…..Significant strides towards achieving the Millennium Development Goals (MDGs) have been made, yet reaching all the goals by the 2015 deadline remains challenging because the world’s poorest are being left behind, a UN report says.

.
The MDG Report 2011 highlights development successes, and says many are due in part to continued economic growth in some developing countries and targeted efforts in critical MDG areas, such as health. Increased funding from many sources, it says, has expanded key programmes, such as treatment for people living with HIV/AIDS.

“Achieving the goals will require equitable and inclusive economic growth — growth that reaches everyone and that will enable all people, especially the poor and marginalized, to benefit from economic opportunities.” the Secretary- General said. “Between now and 2015, we must make sure that promises made become promises kept. World leaders must show not only that they care, but that they have the courage and conviction to act.”

Moving onto a more sustainable path is essential to achieving the MDGs, Mr. Ban said. Ecosystems must be protected to support continued growth and natural environments. The June 2012 UN Conference on Sustainable Development, to take place in Rio de Janeiro and often referred to as Rio+20, offers a major opportunity for new progress….”

MILLENNIUM DEVELOPMENT GOALS

End Poverty and Hunger

Universal Education

Gender Equality

Child Health

Maternal Health

Combat HIV/AIDS

Environmental Sustainability

Global Partnership

* * *
This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues. [DD/ KMC Area]
Washington DC USA

“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.
------------------------------------------------------------------------------------
PAHO/WHO Website
Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html
Twitter http://twitter.com/eqpaho

IMPORTANT: This transmission is for use by the intended
recipient and it may contain privileged, proprietary or
confidential information. If you are not the intended
recipient or a person responsible for delivering this
transmission to the intended recipient, you may not
disclose, copy or distribute this transmission or take
any action in reliance on it. If you received this transmission
in error, please dispose of and delete this transmission.

Thank you.

[EQ] Global Health 2011 conference 29-30 September - Policy for Sustainable and Effective Healthcare

Global Health 2011: Policy for Sustainable and Effective Healthcare

29-30 September 2011, BMA House, London, UK

This inaugural event is a collaboration between BMJ Group and NICE International

Website: http://bit.ly/iBXSnz

Program: http://bit.ly/py8d9P

“…Promoting cost effective, evidence-informed healthcare policy making in low and middle-income countries, as a means of improving global health outcomes; and to:.
• Network, share your experiences, forge links and initiate projects to improve the efficiency, equity and quality of healthcare through better decisions
• Gain a better understanding of current trends and of how decision making can be strengthened locally using international knowledge and expertise
• Meet and connect funding and donor organisations from affluent countries with policy makers and government figures across both rich and poorer countries …”

Keynote speakers:

Recep Akdag, Minister of Health, Turkey

Universal health coverage in Turkey: the challenges and opportunities

Cristian Baeza,

Director, Health, Nutrition and Population, World Bank, USA

How the World Bank is building capacity for local decision making in low and middle income countries

David Brennan,

CEO, AstraZeneca, President, International Federation of Pharmaceutical

Manufacturers International (IFPMA), UK -

The role of the pharmaceutical industry in improving Global Health

Nguyen Thi Kim Tien,

Vice Minister of Health, Vietnam -

Using research to improve policy: lessons from Vietnam

Ferdinando Regalia

Division Chief, Social Protection and Health, Inter-American Development Bank

How IDB is helping to build and strengthen healthcare systems in Latin America

Suwit Wibulpolprasert,

Senior Advisor on Disease Control, Ministry of Health, Thailand –

Expanding access to healthcare in Thailand

Confirmed speakers include

Amanda Glassman, Director, Global Health Policy Program, Center for Global Development, USA
Sir Andy Haines, Professor, London School of Hygiene & Tropical Medicine, UK
David Heymann, Chairman, Health Protection Agency, UK; Professor, London School of Hygiene & Tropical Medicine, UK
Dezhi Yu, Director General, Centre for Project Supervision and Management, Ministry of Health, China
Francoise Cluzeau, Senior Adviser, NICE International, UK
Gerry Bloom, Research Fellow, Institute for Development Studies, UK
Ian Wylie, Chief Executive, Royal College of Obstetricians and Gynaecologists (RCOG), UK
Ignez Tristao, Social Protection Specialist, Inter-American Development Bank, USA
Jeremy Farrar, Director, Oxford University Clinical Research Unit (Vietnam), UK
Klim McPherson, Fellow, New College, University of Oxford, UK
Kun Zhao, Researcher, China National Health Development Research Center, Ministry of Health, China
Laura Sampietro-Colom, President, Health Technology Assessment International (HTAi)
Lloyd Samson, Chair, Pharmaceuticals Benefits Advisory Committee (PBAC), Australia
Martha Gyansa-Lutterodt, Ministry of Health, Ghana

Michael Borowitz, Senior Health Economist, Organization of Economic Cooperation and Development (OECD)
Lord Nigel Crisp, Member of the House of Lords, UK
Parveen Kumar, President, Royal Society of Medicine, UK
Patricio Marquez, Lead Health Specialist, Europe and Central Asia, World Bank
Pham Viet Thanh, Director, Department of Health, Ho Chi Minh City, Vietnam
Richard Barker, Director General, The Association of the British Pharmaceutical Society (ABPI), UK
Richard Smith, Director, UnitedHealth Chronic Disease Initiative, UK
Rob Hecht, Managing Director, Results for Development, USA
Shah Ebrahim, London School of Hygiene & Tropical Medicine, UK; Director, South Asia Centre for Chronic Disease, New Delhi, India
Suwit Wibulpolprasert, Senior Advisor on Disease Control, Ministry of Health, Thailand
Suzanne Hill, Scientist - Medicines, Access and Rational Use, World Health Organisation (WHO)
. Sylvester A. Mensah, Chief Executive, National Health Insurance Scheme, Ghana
Tikki Pang, Director, Research Policy & Cooperation, WHO
T Sundararaman, Executive Director of National Health System Resource Centre, Government of India, New Delhi, India
Tim Kendall, Director, National Collaborating Centre for Mental Health, UK
Tom Treasure, Professor, Clinical Operational Research Unit, University College London, UK
Tony Culyer, Professor, University of York, UK; University of Toronto, Canada
Tsung Mei Tseng, Executive Editor, International Forum, Princeton University, USA

Ursula Giedion, IDB Consultant; Co-director Regional Project on Health Benefits Plans, Inter-American Development Bank, Colombia
Yot Teerawattananon, Leader of Health Intervention and Technology Assessment Program (HITAP), Thailand, Senior Researcher of International Health Policy Programme (IHPP), Ministry of Public Health, Thailand

Twitter http://twitter.com/eqpaho

[EQ] Reasons for a differential impact of policies and interventions on the social gradient of health

Reasons for a differential impact of policies and interventions on the social gradient of health

A literature review

Annemiek Dorgelo, Sarah Pos, Janine Vervoordeldonk, Jan Jansen

Tackling the Gradient in Health - Project

The Netherlands Institute for Health Promotion and Disease Prevention (NIGZ) (lead), the EuroHealthNet (Belgium), Universidad de la Laguna (Spain),
National Institute of Public Health Czech Republic and The Karolinska Institute (Sweden)

Available online at: http://bit.ly/pk9Bv2

The main purpose of this literature review is to map the current knowledge and information about the impact of policies and interventions on the social gradient of health and to find reasons for a differential impact of policies and interventions on health across different SES groups and age groups of children (and their families).

Based on this knowledge and information the purpose is to find an explanation for why people respond differently to policies and interventions. In this chapter policies with an effect or an impact on the health gradient are described.

Content

1. About Gradient

2. Review: introduction

2.1. Objectives

2.2. Partners

3. Methods

3.1. Search Strategy

3.2. Sources of research comprises

3.3. Analyses

4. Results: policies tackling the Social gradient of Health

4.1. Introduction

4.2. European Policies tackling the social health gradient

4.3. Policies in North America tackling the social health gradient

4.4. Conclusions: policies and interventions tackling the gradient

5. Reasons for a differential impact on health inequalities

6. Overall findings: reasons for a differential impact

Reasons for a differential Impact on the social gradient of health (1)

Reasons for a differential impact on health of deprived groups or health inequalities (2)

7. Discussion

Appendix 1: Glossary

Appendix 2: Search terms

Appendix 3: Gradient analyse grid

Appendix 4: Online analyse tool

Twitter http://twitter.com/eqpaho

[EQ] Avoidable Mortality: What it Means and How it is Measured

Avoidable Mortality: What it Means and How it is Measured

Adriana Castelli - Centre for Health Economics, University of York, UK

Olena Nizalova - Kyiv School of Economics and Kyiv Economics Institute

Centre for Health Economics

Alcuin College - University of York - York, UK - June 2011

Available online PDF [44p.] at: http://bit.ly/mYeQPJ

"……….We explore in this research paper the concept of avoidable mortality and how the way it is measured has evolved over time. Starting from an earlier review by Nolte and McKee (2004), we review the empirical studies which have been produced since then.

Finally we appraise the empirical applications of the most recent literature. The concept of "avoidable mortality" refers, broadly speaking, to all those deaths that, given current medical knowledge and technology, could be avoided by the healthcare system through either prevention and/or treatment. It originates from the pioneering work by Rutstein, Berenberg et al. (1976) which introduced the notion of "….„unnecessary untimely deaths‟ as a new way to measuring the quality of medical care.

The most recent empirical literature shows that the notion of avoidable mortality continues to be used to establish the extent to which people are dying from amenable conditions within and/or across countries and over time, and whether socio-economic status and ethnicity are related to mortality from amenable conditions. Most studies use data taken from national death registries, with only two which link the concept of avoidable mortality to routinely collected administrative data of healthcare provision, such as hospitals.

A number of criticisms are raised, with probably the most remarkable being the lack of association found between avoidable mortality and healthcare inputs. No study has actually attempted to use the concept of avoidable mortality within the original aim envisaged by Rutstein, i.e. as a quality indicator of healthcare provision.

We recommend for future work in this area to focus on investigating the link between the provision of healthcare and the concept of avoidable mortality, with a particular emphasis on using routinely collected administrative data, such as hospital discharge data………."

Twitter http://twitter.com/eqpaho

"Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members".
------------------------------------------------------------------------------------
PAHO/WHO Website
Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html
Twitter http://twitter.com/eqpaho